Wockhardt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is PANTOPRAZOLE SODIUM USP, with a corresponding US DMF Number 20763.
Remarkably, this DMF maintains an Active status since its submission on July 31, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 20, 2013, and payment made on October 29, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II